Comparing new HIV treatments for children and teens in Africa
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This trial tests different HIV medicines in children and teenagers to find safer, more effective options. It aims to improve viral suppression and overall health for young people living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 4 weeks to under 15 years
- Weight at least 3 kg (about 6.6 lbs)
- Confirmed HIV infection
- Willing to participate for at least 48 weeks
- Either new to HIV treatment or currently on a dolutegravir-based regimen for at least 6 months with a detectable viral load
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of HIV medicines for children and teenagers under 18 who weigh at least 35 kilograms (about 77 pounds). It aims to see if this treatment is safe and effective for young people who have not been treated before or who are already on a stable HIV treatment.
This study checks how safe and well two HIV medicines work in children ages 6 to under 12. It also measures drug levels in the body to guide dosing and watch for side effects.
This trial tests a new oral HIV medication (VH4524184) in people who have never taken HIV treatment before. It looks at how well the drug controls the virus and how safe it is.
This trial tests better ways to manage HIV when the virus becomes resistant to dolutegravir (DTG), a key medicine. It is for people with high viral load despite being on DTG for at least six months.
This trial studies whether taking dolutegravir plus lamivudine (a simpler two-drug regimen) can work as well as a standard three-drug HIV regimen for people who have reasons they can’t stay on the usual medicines. You may be offered free treatment if you meet the safety checks and can attend follow-up visits.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.